Suchergebnisse - "Gallemann, Dieter"

PubPharm (19)

1

A Novel PBPK Modeling Approach to Assess Cytochrome P450 Mediated Drug-Drug Interaction Potential of the Cytotoxic Prodrug Evofosfamide

enthalten in: CPT: pharmacometrics & systems pharmacology | 2018

von Lüpfert, C. | Dyroff, M. | von Richter, O. | +6

2

Comparison of methods for the prediction of human clearance from hepatocyte intrinsic clearance for a set of reference compounds and an external evaluation set

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2017

von Yamagata, T. | Zanelli, U. | Gallemann, D. | +3

3

Comparison of methods for the prediction of human clearance from hepatocyte intrinsic clearance for a set of reference compounds and an external evaluation set

enthalten in: Xenobiotica | 2017

von Yamagata, T. | Zanelli, U. | Gallemann, D. | +3

4

In vitro and in vivo drug disposition of cilengitide in animals and human

enthalten in: Pharmacology research & perspectives | 2016

von Dolgos, H. | Freisleben, A. | Wimmer, E. | +5

5

Time- and NADPH-dependent inhibition of cytochrome P450 3A4 by the cyclopentapeptide cilengitide : significance of the guanidine group and accompanying spectral changes

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2014

von Bojić, M. | Barbero, L. | Dolgos, H. | +4

6

Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects

enthalten in: Biopharmaceutics & drug disposition | 2012

von Krösser, S. | Marquet, A. | Gallemann, D. | +4

7

Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects

enthalten in: Biopharmaceutics & drug disposition | 2012

von Krösser, S. | Marquet, A. | Gallemann, D. | +4

8

In vitro characterization of sarizotan metabolism : hepatic clearance, identification and characterization of metabolites, drug-metabolizing enzyme identification, and evaluation of cytochrome p450 inhibition

enthalten in: Drug metabolism and disposition: the biological fate of chemicals | 2010

von Gallemann, D. | Wimmer, E. | Höfer, C. | +4

9

In Vitro Characterization of Sarizotan Metabolism: Hepatic Clearance, Identification and Characterization of Metabolites, Drug-Metabolizing Enzyme Identification, and Evaluation of Cytochrome P450 Inhibition

enthalten in: Drug metabolism and disposition | 2010

von Gallemann, D. | Wimmer, E. | Höfer, C. | +4

10

Changes in blood pressure after administration of hydroxocobalamin : relationship to changes in plasma cobalamins-(III) concentrations in healthy volunteers

enthalten in: Clinical toxicology (Philadelphia, Pa.) | 2008

von Uhl, W. | Nolting, A. | Gallemann, D. | +2